Compare HESM & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HESM | PTCT |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | 195 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.7B |
| IPO Year | 2019 | 2006 |
| Metric | HESM | PTCT |
|---|---|---|
| Price | $40.12 | $71.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 17 |
| Target Price | $41.00 | ★ $80.65 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.13% | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,621,300,000.00 | $264,734,000.00 |
| Revenue This Year | $1.59 | N/A |
| Revenue Next Year | $3.10 | $17.70 |
| P/E Ratio | $13.07 | ★ N/A |
| Revenue Growth | 8.41 | ★ 36.19 |
| 52 Week Low | $31.63 | $43.18 |
| 52 Week High | $44.14 | $87.50 |
| Indicator | HESM | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 53.18 |
| Support Level | $38.56 | $62.87 |
| Resistance Level | $40.25 | $79.67 |
| Average True Range (ATR) | 1.01 | 3.10 |
| MACD | 0.22 | 0.14 |
| Stochastic Oscillator | 80.55 | 49.16 |
Hess Midstream LP is a fee-based, growth-oriented limited partnership that owns, operates, develops, and acquires a portfolio of midstream assets. The company provides fee-based services to Chevron Corporation and generates all of its revenue by charging fees for gathering, compressing, and processing natural gas, fractionating NGLs, gathering, terminaling, loading, and transporting crude oil and NGLs, storing and terminaling propane, and gathering and disposing of produced water. It operates through gathering, processing, and storage, and terminaling and export segments, with the gathering segment contributing the maximum share of revenue and comprising natural gas gathering and compression, as well as crude oil gathering and produced water gathering and disposal assets.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.